Israeli Jews

Mattel Announces CFO Transition Plan

Retrieved on: 
Tuesday, October 29, 2019
Other Retail, Other Entertainment, Specialty, Catalog, General Entertainment, Online Retail, Retail, Entertainment, Businesspeople, Barbie, Mattel, Israeli Jews, Ynon Kreiz, Companies, Finance, Chief financial officer

Mattel, Inc. (NASDAQ: MAT) today announced that Chief Financial Officer Joseph J. Euteneuer will leave the Company after a transition period of up to six months.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT) today announced that Chief Financial Officer Joseph J. Euteneuer will leave the Company after a transition period of up to six months.
  • Mattel is conducting a search for its next CFO.
  • Ynon Kreiz, Chairman and Chief Executive Officer of Mattel, said, Joe has been a valued member of our leadership team since joining Mattel two years ago.
  • I thank him for his commitment through the transition of the CFO role.

GTS to Open Office in Tel Aviv

Retrieved on: 
Wednesday, October 23, 2019
Finance, Banking, Professional services, Other Technology, Technology, Israeli Jews, Tel Aviv, Education in Israel

GTS joins the growing ranks of leading financial technology firms establishing a presence in Tel Aviv to attract world class tech talent.

Key Points: 
  • GTS joins the growing ranks of leading financial technology firms establishing a presence in Tel Aviv to attract world class tech talent.
  • The new Tel Aviv GTS office will eventually employ up to 15 people.
  • Leading the office will be GTS Partner, Tel Aviv native, and Tel Aviv University graduate Yaron Katz.
  • Kobi Altman, chief financial officer of Tel Aviv-based ICL commented: As a company with a dual listing in New York and Tel Aviv, we are delighted to welcome our NYSE designated market maker GTS to Tel Aviv as it opens its Israeli office.

Touch-A-Life Foundation to Launch Social Giving Platform at Third Annual Fundraising Event

Retrieved on: 
Tuesday, October 22, 2019
TAL, Israeli Jews

The TAL Giving platform will be unveiled at TAL Annual Day 2019, the third annual Touch-A-Life banquet, open to the public.

Key Points: 
  • The TAL Giving platform will be unveiled at TAL Annual Day 2019, the third annual Touch-A-Life banquet, open to the public.
  • TAL Annual Day 2019 will feature a presentation about TAL Giving, as well as recognize Touch-A-Life 2019 Heroes and provide updates on the annual activities of 2019.
  • "Everyone is welcome to attend our upcoming event to learn more about the exciting activities we have planned for the next year."
  • "As the superintendent of ESUHSD, I am excited and very grateful for the solution developed by the Touch-A-Life Foundation with the launch of the TAL Giving Platform.

Seelos Therapeutics to Participate in Upcoming Investor Conference in November

Retrieved on: 
Friday, October 18, 2019
Israeli Jews

NEW YORK, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, announced today that it will participate in the Jefferies 2019 London Healthcare Conference.

Key Points: 
  • NEW YORK, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, announced today that it will participate in the Jefferies 2019 London Healthcare Conference.
  • The company will host One on One meetings in London, England on Wednesday, November 20th and Thursday, November 21st.
  • Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare disorders.
  • For more information, please visit our website: http://seelostherapeutics.com, the content of which is not incorporated herein by reference.

Stoke Therapeutics Strengthens Leadership Team With Appointments of Robin A. Walker, J.D., as Senior Vice President, Chief Legal Officer and Joan Wood as Head of Human Resources

Retrieved on: 
Wednesday, October 16, 2019
Biotechnology, Pharmaceutical, Genetics, Health, Israeli Jews

Robin and Joan bring deep knowledge of the biopharmaceutical industry and an infectious enthusiasm for building a culture of innovation.

Key Points: 
  • Robin and Joan bring deep knowledge of the biopharmaceutical industry and an infectious enthusiasm for building a culture of innovation.
  • Ms. Walker is an accomplished biotechnology executive and lawyer, with 20 years of in-house and major law firm experience.
  • She joins Stoke from Casebia Therapeutics, where she served as Senior Vice President, Head of Legal and counseled the executive leadership team on corporate, governance, employment, compliance and regulatory matters.
  • Ms. Wood is a global human resources leader, with more than 20 years of experience developing and leading international human resources teams.

Ovid Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference

Retrieved on: 
Monday, September 9, 2019
Chaebol, Lotte Corporation, Lotte, REPLAY, Economy of South Korea, Israeli Jews, Software, Companies

The conference will be held at the Lotte New York Palace Hotel in New York City.

Key Points: 
  • The conference will be held at the Lotte New York Palace Hotel in New York City.
  • A live audio webcast of the presentation can be accessed through the Events & Presentations section of the company's website at investors.ovidrx.com .
  • An archived replay of the webcast will be available on the company's website for two weeks following the live presentation.
  • Ovid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine approach to develop medicines that transform the lives of patients with rare neurological disorders.

Carnival Corporation and Micky and Madeleine Arison Family Foundation Pledge $2 Million for Hurricane Dorian Relief

Retrieved on: 
Wednesday, September 4, 2019
Israeli Jews, Businesspeople, Cruise lines, Micky Arison, Arison family, Business, Economy, Micky, Carnival Corporation & plc, Carnival, Ted Arison

MIAMI, Sept. 4, 2019 /PRNewswire/ -- Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK), the world's largest leisure travel company, today announced that the corporation's philanthropic arm, Carnival Foundation, and its nine global cruise line brands together with the Micky and Madeleine Arison Family Foundation have pledged to donate $2 million in funding and in-kind support for relief efforts in The Bahamas following Hurricane Dorian.

Key Points: 
  • MIAMI, Sept. 4, 2019 /PRNewswire/ -- Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK), the world's largest leisure travel company, today announced that the corporation's philanthropic arm, Carnival Foundation, and its nine global cruise line brands together with the Micky and Madeleine Arison Family Foundation have pledged to donate $2 million in funding and in-kind support for relief efforts in The Bahamas following Hurricane Dorian.
  • Carnival Corporation Chairman Micky Arison and his wife Madeleine are matching the corporation's commitment with a $1 million donation from the Micky and Madeleine Arison Family Foundation.
  • A portion of the combined pledge will immediately go to support efforts being managed by Direct Relief, an international humanitarian organization that provides critical medications and supplies during emergency situations.
  • Carnival Foundation is dedicated to creating positive change through empowering youth, enhancing education and strengthening families in the communities where Carnival Corporation employees live and work.

Seelos Therapeutics to Participate in Upcoming Investor Conference in September

Retrieved on: 
Wednesday, September 4, 2019
Israeli Jews

NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, announced today that it will participate in the Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease Companies.

Key Points: 
  • NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, announced today that it will participate in the Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease Companies.
  • The company will host One on One meetings in New York, NY on Monday, September 23rd and Tuesday, September 24th.
  • Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare disorders.
  • Seelos is based in New York, New York.

Ovid Therapeutics Announces Participation in Two Upcoming Investor Conferences

Retrieved on: 
Tuesday, September 3, 2019
Israeli Jews, Jeremy Levin, Business

NEW YORK, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced its participation in two upcoming investor conferences in September:

Key Points: 
  • NEW YORK, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced its participation in two upcoming investor conferences in September:
    Members of the Companys management team will participate in one-on-one meetings with investors on Thursday, September 5, 2019.
  • Jeremy Levin, DPhil, MB, BChir, Chairman and Chief Executive Officer of Ovid, will present a corporate overview on Tuesday, September 24, 2019 at 9:00 a.m. EDT.
  • Ovid Therapeutics (NASDAQ: OVID) is a New York-based biopharmaceutical company using its BoldMedicine approach to develop medicines that transform the lives of patients with rare neurological disorders.
  • Ovid is also developing OV935 (soticlestat) in collaboration with Takeda Pharmaceutical Company Limited for the potential treatment of rare developmental and epileptic encephalopathies (DEE).

Sheba Medical Center, Tel HaShomer & Telesofia Medical Announce Cutting-Edge Telemedicine Software - A Game-Changer in Treating Cancer Patients in Their Own Homes

Retrieved on: 
Monday, August 26, 2019
Sheba Medical Center, Tel HaShomer, Israeli Jews, Cities in Israel, Health, Chaim Sheba, Israel

It will be offered to several hundred patients within the gastrointestinal oncology unit during the next few months.

Key Points: 
  • It will be offered to several hundred patients within the gastrointestinal oncology unit during the next few months.
  • The app allows patients to report side effects and other issues in real time to their doctors.
  • Rami Cohen, CEO of Telesofia Medical, added, "We are proud to be working with Sheba, as we share similar values.
  • Born together with Israel in 1948, Sheba Medical Center, Tel HaShomer is the largest and most comprehensive medical center in the Middle East.